You are using an older browser version. Please use a supported version for the best MSN experience.

COVID-19 treatment Bamlanivimab goes unused

COVID-19 vaccines have come fast but treatments for the disease are still limited. When a Canadian company developed Bamlanivimab, a new monoclonal antibody drug, Ottawa spent millions on doses. But after the rush to buy them they've sat on shelves for months, unused.
image beaconimage beaconimage beacon